Enlivex Therapeutics Ltd (ENLV) — Financial Flexibility Index
Enlivex Therapeutics Ltd (ENLV) has a Financial Flexibility Index of -0.66x as of September 2025. Free cash flow of ILA-2.27 Million (operating CF ILA-2.30 Million minus capex ILA23.55K) represents -1% of total liabilities (ILA3.46 Million). Check Enlivex Therapeutics Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Enlivex Therapeutics Ltd Financial Flexibility Index (2012–2024)
Historical Financial Flexibility Index trend for Enlivex Therapeutics Ltd across 13 annual periods. See Enlivex Therapeutics Ltd (ENLV) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Enlivex Therapeutics Ltd (2012–2024)
Year-by-year free cash flow to debt coverage for Enlivex Therapeutics Ltd. For the full company profile including market capitalisation, see Enlivex Therapeutics Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.15x | ILA-12.90 Million | ILA-13.01 Million | ILA4.10 Million | ▲ +8.8% |
| 2023 | -3.45x | ILA-23.29 Million | ILA-23.52 Million | ILA6.75 Million | ▼ -135.5% |
| 2022 | -1.47x | ILA-15.83 Million | ILA-23.95 Million | ILA10.80 Million | ▲ +6.9% |
| 2021 | -1.57x | ILA-15.92 Million | ILA-17.54 Million | ILA10.11 Million | ▲ +23.2% |
| 2020 | -2.05x | ILA-9.99 Million | ILA-11.01 Million | ILA4.87 Million | ▼ -88.0% |
| 2019 | -1.09x | ILA-6.85 Million | ILA-7.04 Million | ILA6.28 Million | ▲ +46.3% |
| 2018 | -2.03x | ILA-2.70 Million | ILA-3.16 Million | ILA1.33 Million | ▲ +85.3% |
| 2017 | -13.80x | ILA-6.35 Million | ILA-6.35 Million | ILA460.00K | ▼ -72.3% |
| 2016 | -8.01x | ILA-15.47 Million | ILA-15.49 Million | ILA1.93 Million | ▼ -56.8% |
| 2015 | -5.11x | ILA-13.20 Million | ILA-13.25 Million | ILA2.58 Million | ▼ -168.0% |
| 2014 | -1.91x | ILA-4.35 Million | ILA-4.41 Million | ILA2.28 Million | ▲ +71.1% |
| 2013 | -6.59x | ILA-863.00K | ILA-865.00K | ILA131.00K | ▼ -258.1% |
| 2012 | -1.84x | ILA-149.00K | ILA-149.00K | ILA81.00K | — |